Diagnostic Significance of Edetate Disodium Calcium Testing in Children With Increased Lead Absorption

Paul Saenger, John F. Rosen, Morri E. Markowitz

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Conventional screening tests (blood lead and erythrocyte protoporphyrin levels) may not accurately reflect the magnitude of lead storage in children with mild to moderate increases in lead absorption, as assessed by edetate disodium calcium testing. Children with blood lead levels higher than 30 μg/dL and erythrocyte protoporphyrin levels higher than 50 pg/dL warrant careful measurement of the size of chelatable, potentially toxic lead stores. Edetate disodium calcium testing provides a more precise basis for therapeutic decisions in a child with mild to moderate increases in lead absorption.

Original languageEnglish (US)
Pages (from-to)312-315
Number of pages4
JournalAmerican Journal of Diseases of Children
Volume136
Issue number4
DOIs
StatePublished - 1982

Fingerprint

Edetic Acid
Erythrocytes
Poisons
Hematologic Tests
Lead
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Diagnostic Significance of Edetate Disodium Calcium Testing in Children With Increased Lead Absorption. / Saenger, Paul; Rosen, John F.; Markowitz, Morri E.

In: American Journal of Diseases of Children, Vol. 136, No. 4, 1982, p. 312-315.

Research output: Contribution to journalArticle

@article{539221af300b4e429efaac30e7362be8,
title = "Diagnostic Significance of Edetate Disodium Calcium Testing in Children With Increased Lead Absorption",
abstract = "Conventional screening tests (blood lead and erythrocyte protoporphyrin levels) may not accurately reflect the magnitude of lead storage in children with mild to moderate increases in lead absorption, as assessed by edetate disodium calcium testing. Children with blood lead levels higher than 30 μg/dL and erythrocyte protoporphyrin levels higher than 50 pg/dL warrant careful measurement of the size of chelatable, potentially toxic lead stores. Edetate disodium calcium testing provides a more precise basis for therapeutic decisions in a child with mild to moderate increases in lead absorption.",
author = "Paul Saenger and Rosen, {John F.} and Markowitz, {Morri E.}",
year = "1982",
doi = "10.1001/archpedi.1982.03970400030008",
language = "English (US)",
volume = "136",
pages = "312--315",
journal = "JAMA Pediatrics",
issn = "2168-6203",
publisher = "American Medical Association",
number = "4",

}

TY - JOUR

T1 - Diagnostic Significance of Edetate Disodium Calcium Testing in Children With Increased Lead Absorption

AU - Saenger, Paul

AU - Rosen, John F.

AU - Markowitz, Morri E.

PY - 1982

Y1 - 1982

N2 - Conventional screening tests (blood lead and erythrocyte protoporphyrin levels) may not accurately reflect the magnitude of lead storage in children with mild to moderate increases in lead absorption, as assessed by edetate disodium calcium testing. Children with blood lead levels higher than 30 μg/dL and erythrocyte protoporphyrin levels higher than 50 pg/dL warrant careful measurement of the size of chelatable, potentially toxic lead stores. Edetate disodium calcium testing provides a more precise basis for therapeutic decisions in a child with mild to moderate increases in lead absorption.

AB - Conventional screening tests (blood lead and erythrocyte protoporphyrin levels) may not accurately reflect the magnitude of lead storage in children with mild to moderate increases in lead absorption, as assessed by edetate disodium calcium testing. Children with blood lead levels higher than 30 μg/dL and erythrocyte protoporphyrin levels higher than 50 pg/dL warrant careful measurement of the size of chelatable, potentially toxic lead stores. Edetate disodium calcium testing provides a more precise basis for therapeutic decisions in a child with mild to moderate increases in lead absorption.

UR - http://www.scopus.com/inward/record.url?scp=0020070688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020070688&partnerID=8YFLogxK

U2 - 10.1001/archpedi.1982.03970400030008

DO - 10.1001/archpedi.1982.03970400030008

M3 - Article

C2 - 6803578

AN - SCOPUS:0020070688

VL - 136

SP - 312

EP - 315

JO - JAMA Pediatrics

JF - JAMA Pediatrics

SN - 2168-6203

IS - 4

ER -